US Patent Issued to AUTOLUS on May 20 for "Cell comprising a chimeric antigen receptor or a transgenic T-cell receptor and comprising a chimeric TNF receptor" (British Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,942, issued on May 20, was assigned to AUTOLUS Ltd. (London).

"Cell comprising a chimeric antigen receptor or a transgenic T-cell receptor and comprising a chimeric TNF receptor" was invented by Martin Pule (London) and Marco Della Peruta (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a cell which comprises; (i) a chimeric antigen receptor (CAR) or a transgenic T-cell receptor (TCR); and (ii) a chimeric TNF receptor (TNFR) which comprises (a) a binding domain which is capable of binding a TNFR ligand; and (b) a TNFR signalling domain."

The patent was filed on Dec. 14, 2018, under Application No. 16/772,260....